30
Participants
Start Date
March 1, 2018
Primary Completion Date
October 1, 2018
Study Completion Date
February 1, 2019
iv dexketoprofen trometamol (Arveles 50mg/2mL; UFSA, İstanbul, Turkey)
The primary predictor variable was preventive analgesia group. Patients were randomly divided in two groups. 50 mg iv dexketoprofen trometamol (Arveles 50mg/2mL; UFSA, İstanbul, Turkey) were administrated 30 minutes before incision in the treatment group (dexketoprofen trometamol n= 15
Steril Salin (control)
30 minutes before incision in the treatment group (dexketoprofen trometamol n= 15) and iv sterile saline were administrated 30 minutes before incision in the placebo group (saline n= 15).
Yusuf Nuri Kaba, Kayseri
TC Erciyes University
OTHER